JENBURKT PHARMACEUTICALS
|
The Current P/E Ratio of JENBURKT PHARMACEUTICALS is 13.67.
| Share Price | ₹1,007.3 | Mar 20,2026 |
| Market Cap | ₹443.2 Cr | |
| Earnings-TTM | ₹32.4 Cr | TTM-Standalone Results |
| Price/Earnings | 13.67x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JENBURKT PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹443.2 Cr] as on Mar 20,2026
(/) Earnings [ ₹32.4 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 13.67x ]
Thus, for JENBURKT PHARMACEUTICALS , the investors are currently willing to pay 13.67 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JENBURKT PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JENBURKT PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JENBURKT PHARMACEUTICALS
PE Ratio Performance Analysis for JENBURKT PHARMACEUTICALS
- JENBURKT PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.06x.
- JENBURKT PHARMACEUTICALS 's operated at median p/e ratio of 11.71x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JENBURKT PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 13.93x.
- JENBURKT PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 11.08x.
How does JENBURKT PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JENBURKT PHARMACEUTICALS | 32.42 | 13.67 | 443.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 38.77 | 426,470.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 65.35 | 161,996.0 |
| CIPLA LTD | 4,544.70 | 22.32 | 101,445.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.57 | 144,440.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.68 | 108,417.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.95 | 82,555.3 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.16 | 89,615.2 |
| LUPIN LTD | 4,669.18 | 22.73 | 106,146.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 21.35 | 75,004.7 |
| ABBOTT INDIA LTD | 1,524.13 | 37.27 | 56,804.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JENBURKT PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 13.67x |
| Max industry PE | 65.35x |
| Median industry PE | 22.73x |
| Average industry PE | 33.53x |
You may also like the below Video Courses